Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Deborah Waterhouse. Director active across 1 company, notably GSK plc. Aggregated, 104 reports have been published. Activity tracked since 9 August 2023. The latest transaction was filed on 11 August 2026 (Purchase). Regulator: RNS (LSE). All data is accessible without signup.
Companies and markets linked to Deborah Waterhouse Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 104 total
● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 11 Aug 2026 · GSK plc 14 shares @ £19.3493 London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9721245-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 11 Aug 2026 · GSK plc 14 shares @ £19.3493 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63FCA-NSM:802aebe3-75c1-4ba5-8333-3c8ccb6de1b0-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 10 Jul 2026 · GSK plc 867 shares @ £19.595 0.0022% mcap 0.1% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9668630-22 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Jul 2026 · GSK plc 1,070.064 shares @ £19.6297 0.0027% mcap 0.1% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9668630-9 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Jul 2026 · GSK plc 0
London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:0920c70b-f075-4c99-aba0-46720a29730a-9 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Jul 2026 · GSK plc 12 shares @ £19.6292 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9666294-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Jul 2026 · GSK plc 58 shares @ £19.629 0.0001% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9666294-15 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Jul 2026 · GSK plc 12 shares @ £19.6292 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Jul 2026 · GSK plc 58 shares @ £19.629 0.0001% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-15 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9614374-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:03338973-0058-4811-9fe5-7b22157346a2-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 12 May 2026 · GSK plc 12 shares @ £18.778 0.0000% mcap 100.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9569357-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 12 May 2026 · GSK plc 12 shares @ £18.6558 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:eaad27f1-a91f-4bc4-815a-149202956de0-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 14 Apr 2026 · GSK plc 824 shares @ £21.67 0.0000% mcap 0.1% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-8 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 13 Apr 2026 · GSK plc 12 shares @ £21.7083 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:bae2311e-28b0-4835-a894-0209eedccba9-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Apr 2026 · GSK plc 0
London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-13 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Apr 2026 · GSK plc 56 shares @ £21.3387 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-7 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 10 Mar 2026 · GSK plc 12 shares @ £20.7167 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 13 Feb 2026 · GSK plc 76,587 shares @ £21.6002 9.7% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-23 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 13 Feb 2026 · GSK plc 162,949 shares 0
N/AISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-22 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 12 Feb 2026 · GSK plc 18,543 shares @ £21.50 2.3% of flow N/AISIN ISIN GB00BN7SWP63RNS:6207777f-2477-470b-868f-21f92714189a-8 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 12 Feb 2026 · GSK plc 136,579 shares @ £21.50 17.3% of flow N/AISIN ISIN GB00BN7SWP63RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-12 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Feb 2026 · GSK plc 21,009 shares @ £22.0267 2.7% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-15 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 10 Feb 2026 · GSK plc 0
N/AISIN ISIN GB00BN7SWP63RNS:8df504c6-f415-410b-a190-e5ddcfc0debe-2 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Feb 2026 · GSK plc 44,631 shares 0
N/AISIN ISIN GB00BN7SWP63RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-14 25 of 104 declarations
Load more (79 remaining) About Deborah Waterhouse Deborah Waterhouse is a declarant linked to GSK plc, where the listed role is CEO, ViiV Healthcare and President, Global Health, GSK. She has 94 filings in total, and among the sampled recent filings from 2023-08-10 to 2026-06-12, purchases amount to EUR 22,690 and sales to EUR 8,811,372.